Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M

Kenneth S. Thress(AstraZeneca (United States)), Cloud P. Paweletz(Dana-Farber Cancer Institute), Enriqueta Felip(Hebron University), Byoung Chul Cho(Yonsei University), Daniel Stetson(AstraZeneca (United States)), Brian Dougherty(AstraZeneca (United States)), Zhongwu Lai(AstraZeneca (United States)), Aleksandra Markovets(AstraZeneca (United States)), Ana Vivancos(Vall d'Hebron Institute of Oncology), Yanan Kuang(Dana-Farber Cancer Institute), Dalia Ercan(Dana-Farber Cancer Institute), Sarah E Matthews(Dana-Farber Cancer Institute), Mireille Cantarini(AstraZeneca (United Kingdom)), J. Carl Barrett(AstraZeneca (United States)), Pasi A. Jänne(Dana-Farber Cancer Institute), Geoffrey R. Oxnard(Dana-Farber Cancer Institute)
Nature Medicine
May 4, 2015
10.1038/nm.3854
Cited by 1,535Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis